{
  "meta": {
    "title": "9_Investigations_In_Breast_Diseases",
    "url": "https://brainandscalpel.vercel.app/9-investigations-in-breast-diseases-ffee557f.html",
    "scrapedAt": "2025-11-30T12:36:19.385Z"
  },
  "questions": [
    {
      "text": "What is the recommended age for starting screening mammography?",
      "choices": [
        {
          "id": 1,
          "text": "40 years"
        },
        {
          "id": 2,
          "text": "45 years"
        },
        {
          "id": 3,
          "text": "50 years"
        },
        {
          "id": 4,
          "text": "55 years"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The <strong>recommended age</strong> for women to start annual screening mammography is <strong>40 years</strong> of age.</p>\n<ul>\n<li><span><strong>Until 44 years of age</strong>, it is her<strong>&nbsp;individual choice</strong> to decide on whether she wants screening mammography or not. </span></li>\n<li><span>For ages<strong> between 45 and 49 years,</strong> it is <strong>mandatory</strong> to get&nbsp;<span><strong>annua</strong><strong>l</strong></span><span> breast</span> <span>screening done. </span></span></li>\n<li><span><span>After the age of <strong>50 years, </strong>it is advised that women get a <strong>second yearly</strong> screening done.</span></span></li>\n</ul><p><strong>October </strong>is the <strong>Breast Cancer Awareness Month</strong>&nbsp;across the world. It helps to increase attention and support for the awareness, early detection, and treatment as well as palliative care of this disease.</p><hr><h3>Related Pearl: Breast Cancer Screening</h3><p><strong>Breast Cancer Screening</strong></p>\n<p>Individuals are encouraged to conduct a <strong>risk assessment by 25 years of age</strong>. This helps classify them into <strong>average risk</strong> or <strong>increased risk groups</strong>.</p>\n<p>Recommendations<strong>:</strong>&nbsp;</p>\n<ol>\n<li aria-level=\"1\"><strong>Average-risk</strong>&nbsp;(no known genetic or family history of breast cancer)</li>\n<ul>\n<li aria-level=\"1\">25-39 years of age: clinical breast examination every 1-3 years;&nbsp;</li>\n<li aria-level=\"2\">&ge; 40 years of age: clinical breast examination and mammogram annually</li>\n</ul>\n<li aria-level=\"1\"><strong>High-risk </strong>(positive family or genetic history of breast cancer)</li>\n<ul>\n<li aria-level=\"2\">Consult a healthcare professional&nbsp;every <strong>6-12 months</strong> <strong>after 21 years of age</strong></li>\n<li aria-level=\"2\"><strong>Annual mammogram or MRI</strong> from 25 years of age or 10 years prior to the age at which the youngest family member was diagnosed with breast cancer (whichever is earliest)</li>\n</ul>\n<li aria-level=\"1\"><strong>Asymptomatic women</strong> with <strong>previously treated breast cancer</strong></li>\n<ul>\n<li aria-level=\"2\">Consult a healthcare professional&nbsp;every <strong>6-12 months</strong></li>\n<li aria-level=\"2\"><strong>Annual mammogram</strong></li>\n<li aria-level=\"2\">Annual MRI to be considered</li>\n</ul>\n<li aria-level=\"1\">Mammogram and USG are&nbsp;<strong>not contraindicated</strong> in <strong>pregnant and breastfeeding</strong> women</li>\n</ol>\n<p><strong>High-risk patients</strong> for breast cancer:</p>\n<ol>\n<li aria-level=\"1\">Women (or a first-degree relative) with a known BRCA1 or BRCA2 mutation or TP53 or PTEN genes</li>\n<li aria-level=\"1\">Two first-degree relatives with breast cancers with or without gene mutations</li>\n<li aria-level=\"1\">Women with a history of chest irradiation between the ages of 10 and 30</li>\n<li aria-level=\"1\">Women with previously biopsy-proven breast cancer</li>\n<li aria-level=\"1\">Women with &ge; 20% lifetime risk for breast cancer based on breast cancer risk models</li>\n</ol>\n<p>*According to <strong>NCCN 2022 guidelines</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0347",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is false regarding screening mammography?",
      "choices": [
        {
          "id": 1,
          "text": "Sensitivity of the test will increase with her age."
        },
        {
          "id": 2,
          "text": "It is best performed in the 2nd half of her menstrual cycle."
        },
        {
          "id": 3,
          "text": "Mediolateral oblique view will show the greatest volume of her breast tissue."
        },
        {
          "id": 4,
          "text": "Craniocaudal view will provide better visualization of the medial aspect of her breast."
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Mammography is best performed in the <strong>1st half of the menstrual cycle</strong>, as breast tissue is<strong> less dense</strong> in the follicular phase. Also, in the <strong>2nd half of the menstrual cycle</strong>, since ovulation occurs and there is a chance for pregnancy, the <strong>radiation</strong> can potentially <strong>affect the embryo</strong>.&nbsp;</p>\n<p>The<strong> sensitivity</strong> of mammography&nbsp;<strong>increases with age</strong>, as the breast tissue becomes <strong>less dense</strong>.&nbsp;</p>\n<p>It involves 2 standard views:&nbsp;</p>\n<ol>\n<li aria-level=\"1\">Mediolateral oblique (<strong>MLO) </strong>view- covers a <strong>greater volume</strong> of breast tissue, including the upper outer quadrant and the axillary tail of Spence.</li>\n<li aria-level=\"1\">Craniocaudal (<strong>CC</strong>)&nbsp;view- provides <strong>better</strong> <strong>visualization of the medial aspect</strong> of the breast.</li>\n</ol>\n<p>Mammography uses low-voltage, high-amperage X-rays. The radiation dose from mammography is around <strong>0.1 cGy</strong> per study.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0346",
      "difficulty": "medium"
    },
    {
      "text": "A 50-year-old woman underwent screening mammography. Which of the following findings in her mammogram is least suggestive of a malignancy?",
      "choices": [
        {
          "id": 1,
          "text": "Irregular mass"
        },
        {
          "id": 2,
          "text": "Wide halo"
        },
        {
          "id": 3,
          "text": "Macrocalcification"
        },
        {
          "id": 4,
          "text": "Spiculated margins"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Macrocalcification</strong> in a lesion is <strong>least</strong> suggestive of a <strong>malignancy.</strong> It is commonly seen in <strong>benign breast disorders</strong>. <strong>Microcalcification</strong> (&lt;0.5 mm in diameter) is suggestive of <strong>malignancy</strong>.</p>\n<p>Table: Mammographic appearance of benign and malignant masses&nbsp;&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Benign</strong></td>\n<td><strong>Malignant</strong></td>\n</tr>\n<tr>\n<td><strong>Opacity</strong></td>\n<td>\n<ul>\n<li>Low density</li>\n<li>Homogenous</li>\n<li>Smooth margin</li>\n<li>Thin halo</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>High density</li>\n<li>Not homogenous</li>\n<li>Ill-defined margin, irregular stellate spiculated margin, comet tail</li>\n<li>Wide halo</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Calcification</strong></td>\n<td>Macrocalcification (&gt;0.5 mm)</td>\n<td>Microcalcification (&lt;0.5 mm)</td>\n</tr>\n<tr>\n<td><strong>Breast parenchyma</strong></td>\n<td>Normal</td>\n<td>Architectural distortion</td>\n</tr>\n<tr>\n<td><strong>Nipple/areola</strong></td>\n<td>Normal</td>\n<td>Retraction</td>\n</tr>\n<tr>\n<td><strong>Skin</strong></td>\n<td>Normal</td>\n<td>Thickening</td>\n</tr>\n<tr>\n<td><strong>Cooper ligaments</strong></td>\n<td>Normal</td>\n<td>\n<p>Thickening, increase in number</p>\n</td>\n</tr>\n<tr>\n<td><strong>Ducts</strong></td>\n<td>Normal</td>\n<td>Focal dilatation</td>\n</tr>\n<tr>\n<td><strong>Subcutaneous and mammary space</strong></td>\n<td>Normal</td>\n<td>Obliteration</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Below is an image showing a malignant breast mass with ill-defined, spiculated margins and&nbsp;microcalcifications.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/62a1c0029973463aaf883df317766d1fx1024x700.jpeg\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0351",
      "difficulty": "easy"
    },
    {
      "text": "Which pattern of microcalcification seen in a patient’s mammography report would indicate the maximum risk of malignancy?",
      "choices": [
        {
          "id": 1,
          "text": "Cluster microcalcification"
        },
        {
          "id": 2,
          "text": "Diffuse microcalcification"
        },
        {
          "id": 3,
          "text": "Segmental microcalcification"
        },
        {
          "id": 4,
          "text": "Regional microcalcification"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Cluster microcalcification</strong> in mammography indicates the <strong>maximum </strong>risk of malignancy.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2c7c56294ed74b5e90a261c87b177a99x440x252.JPEG\" alt=\"Explanation Image\"><p>Breast cancer, the most common cancer globally, accounts for 2.3 million new cases annually, with 70% of deaths occurring in resource-constrained areas due to late detection. WHO’s Global Breast Cancer Initiative (GBCI) aims to reduce mortality by 2.5% annually by 2040 through early detection, timely diagnosis, and comprehensive care. This Breast Cancer Awareness Month, under the theme <strong>'No one should face breast cancer alone'</strong> highlights the need for early detection, patient support, and stronger partnerships to address disparities and improve outcomes.</p><hr><h3>Related Pearl: Types of microcalcification indicating malignancy</h3><p>In decreasing order of risk of malignancy-</p>\n<ul>\n<li>Cluster microcalcification (maximum risk)</li>\n<li>Linear microcalcification</li>\n<li>Segmental microcalcification</li>\n<li>Diffuse microcalcification (minimum risk)</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0352",
      "difficulty": "medium"
    },
    {
      "text": "Match the following types of calcifications with the diseases they are associated with.<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td>Type of calcification</td>\n<td>Disease</td>\n</tr>\n<tr>\n<td>A. Popcorn calcification</td>\n<td>i) Fibrocystic disease</td>\n</tr>\n<tr>\n<td>B. Lead- pipe calcification</td>\n<td>ii) Duct ectasia</td>\n</tr>\n<tr>\n<td>C. Broken needle calcification</td>\n<td>iii) Traumatic fat necrosis</td>\n</tr>\n<tr>\n<td>D. Tea- cup calcification</td>\n<td>iv) Fibroadenoma</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "A-iii B-ii C-i D-iv"
        },
        {
          "id": 2,
          "text": "A-iv B-iii C-ii D-i"
        },
        {
          "id": 3,
          "text": "A-i B-iii C-ii D-iv"
        },
        {
          "id": 4,
          "text": "A-ii B-iv C-iii D-i"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Popcorn calcification </strong>is seen in <strong>fibroadenoma.</strong></p>\n<p><strong>Lead-pipe/egg-shell calcification</strong> is seen in <strong>traumatic fat necrosis</strong>.</p>\n<p><strong>Broken-needle type of calcification</strong> is seen in <strong>duct ectasia</strong>.</p>\n<p><strong>Tea-cup calcification</strong> is seen in <strong>fibrocystic disease</strong>.</p>\n<p><strong>Popcorn calcification:</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/47a9fc6819e745b5bcebdb85e43f79fex630x520.JPEG\" alt=\"Explanation Image\"><p>&nbsp;<strong>Lead-pipe/egg-shell calcification:</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e6a5446052284594900f5e6b5d44e4fcx172x227.JPEG\" alt=\"Explanation Image\"><p><strong>Broken-needle type of calcification:</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b95f21ef2bb94751b0ebc6e6ae44f1bax841x1024.JPEG\" alt=\"Explanation Image\"><p><strong>Tea-cup calcification:</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7296ae6662c446cb8341bdf47f5057bbx512x559.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0354",
      "difficulty": "medium"
    },
    {
      "text": "A 58-year-old woman presents with complaints of a painless lump in her left breast which she noticed during a routine self-examination. On palpation, a hard lump with irregular margins and enlarged left axillary lymph nodes were found. Which among the following is the best modality to detect malignancy in her case?",
      "choices": [
        {
          "id": 1,
          "text": "2D mammography"
        },
        {
          "id": 2,
          "text": "Digital mammography"
        },
        {
          "id": 3,
          "text": "Tomosynthesis with conventional mammography"
        },
        {
          "id": 4,
          "text": "Full-field digital mammography"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Tomosynthesis (3D mammography) performed along with conventional 2D mammography</strong> is the best investigation among the given options to detect breast carcinoma.&nbsp;</p>\n<p><strong>Breast Tomosynthesis</strong> is typically performed in conjunction <strong>with conventional mammography</strong>. Hence, the radiation dose is doubled. However, the <strong>accuracy is improved</strong> and false positives are lesser. It can be used for <strong>dense breasts</strong> and those with <strong>high-risk factors</strong>.</p>\n<p><strong>Screen-film mammography</strong> is the conventional 2D mammography.</p>\n<p><strong>Digital mammography/full-field digital mammography</strong> uses digital technology instead of films. The diagnostic accuracy is similar to that of screen-film mammography. A minor advantage is the greater accuracy in predicting lesions in dense breasts.</p>\n<p>Note: Overall, the <strong>best modality</strong> for detecting breast carcinoma is <strong>MRI.</strong></p>\n<p>The below image shows a comparison of 2D mammogram vs. 3D mammogram:</p><img src=\"https://cdn1.dailyrounds.org/uploads/0c5f19f8e66e4745ba5b400e629645f9x843x817.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9856",
      "difficulty": "medium"
    },
    {
      "text": "A mammogram done for a 45-year-old female patient with a breast lump was reported as BIRADS category 0. What is it suggestive of?",
      "choices": [
        {
          "id": 1,
          "text": "Negative"
        },
        {
          "id": 2,
          "text": "Incomplete"
        },
        {
          "id": 3,
          "text": "Probably benign"
        },
        {
          "id": 4,
          "text": "Suspicious abnormality"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Category/score <strong>0</strong> in BIRADS suggests an&nbsp;<strong>incomplete assessment.</strong></p>\n<p>All&nbsp;breast&nbsp;imaging&nbsp;should be reported by&nbsp;BIRADS&nbsp;(breast imaging-reporting and data system).</p><hr><h3>Related Pearl: BIRADS - Breast Imaging Reporting and Data System</h3><p>Breast Imaging Reporting and Data System <strong>(BI-RADS)</strong> standardizes the reporting for mammography and ultrasonography and helps guide decision making:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Category</strong></td>\n<td><strong>Definition</strong></td>\n<td><strong>% Chances of Malignancy</strong></td>\n<td><strong>Follow-up</strong></td>\n</tr>\n<tr>\n<td>0</td>\n<td>Incomplete assessment</td>\n<td>Not applicable</td>\n<td>Additional imaging evaluation</td>\n</tr>\n<tr>\n<td>1</td>\n<td>Negative</td>\n<td>Essentially 0%</td>\n<td>Annual screening</td>\n</tr>\n<tr>\n<td>2</td>\n<td>Benign finding</td>\n<td>Essentially 0%</td>\n<td>Annual screening</td>\n</tr>\n<tr>\n<td>3</td>\n<td>Probably benign finding</td>\n<td>&gt;0% but ≤2%</td>\n<td>6 monthly mammograms for the next 2 years</td>\n</tr>\n<tr>\n<td>4\n<p> </p>\n</td>\n<td colspan=\"2\">\n<p>4A: low level of suspicion for malignancy &gt;2% to ≤10%</p>\n<p>4B: moderate suspicion for malignancy &gt;10% to ≤50%</p>\n<p>4C: high suspicion for malignancy &gt;50% to &lt;95%</p>\n</td>\n<td>Biopsy</td>\n</tr>\n<tr>\n<td>5</td>\n<td>Highly suggestive of malignancy </td>\n<td>≥95%</td>\n<td>Appropriate action should be taken </td>\n</tr>\n<tr>\n<td>6</td>\n<td colspan=\"2\">Known biopsy-proven malignancy</td>\n<td>Appropriate treatment</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0355",
      "difficulty": "easy"
    },
    {
      "text": "A 48-year-old woman with a lump in her right breast was advised to undergo mammography which was reported as BIRADS 3. What will be the appropriate next step of management in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Trucut biopsy"
        },
        {
          "id": 2,
          "text": "Routine annual screening"
        },
        {
          "id": 3,
          "text": "MRI breast"
        },
        {
          "id": 4,
          "text": "Follow-up every 6 months for 2 years"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>A <strong>BIRADS score of 3</strong> means that it is <strong>probably a benign lesion</strong>. The next appropriate step is to <strong>follow up</strong> with this patient <strong>every 6 months for the next 2 years</strong>.</p>\n<p>During this period, the score can either downgrade to BIRADS 2 or upgrade to BIRADS 4 or 5.</p><hr><h3>Related Pearl: BIRADS - Breast Imaging Reporting and Data System</h3><p>Breast Imaging Reporting and Data System <strong>(BI-RADS)</strong> standardizes the reporting for mammography and ultrasonography and helps guide decision making:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Category</strong></td>\n<td><strong>Definition</strong></td>\n<td><strong>% Chances of Malignancy</strong></td>\n<td><strong>Follow-up</strong></td>\n</tr>\n<tr>\n<td>0</td>\n<td>Incomplete assessment</td>\n<td>Not applicable</td>\n<td>Additional imaging evaluation</td>\n</tr>\n<tr>\n<td>1</td>\n<td>Negative</td>\n<td>Essentially 0%</td>\n<td>Annual screening</td>\n</tr>\n<tr>\n<td>2</td>\n<td>Benign finding</td>\n<td>Essentially 0%</td>\n<td>Annual screening</td>\n</tr>\n<tr>\n<td>3</td>\n<td>Probably benign finding</td>\n<td>&gt;0% but ≤2%</td>\n<td>6 monthly mammograms for the next 2 years</td>\n</tr>\n<tr>\n<td>4\n<p> </p>\n</td>\n<td colspan=\"2\">\n<p>4A: low level of suspicion for malignancy &gt;2% to ≤10%</p>\n<p>4B: moderate suspicion for malignancy &gt;10% to ≤50%</p>\n<p>4C: high suspicion for malignancy &gt;50% to &lt;95%</p>\n</td>\n<td>Biopsy</td>\n</tr>\n<tr>\n<td>5</td>\n<td>Highly suggestive of malignancy </td>\n<td>≥95%</td>\n<td>Appropriate action should be taken </td>\n</tr>\n<tr>\n<td>6</td>\n<td colspan=\"2\">Known biopsy-proven malignancy</td>\n<td>Appropriate treatment</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9858",
      "difficulty": "medium"
    },
    {
      "text": "An anxious 45-year-old woman presented with complaints of a lump over her left breast for 2 months. The patient underwent mammography, and the lump was categorized as BIRADS 4a. What is the likelihood of her lesion being malignant?",
      "choices": [
        {
          "id": 1,
          "text": "80-95 %"
        },
        {
          "id": 2,
          "text": "60-80%"
        },
        {
          "id": 3,
          "text": "11- 50%"
        },
        {
          "id": 4,
          "text": "2-10%"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>There is a <strong>2-10%</strong> likelihood for a lesion with <strong>BIRADS 4a</strong> to be malignant.</p>\n<p><strong>BIRADS Categories/Grades</strong></p>\n<p>Grades 1 and 2: 0% chance of being malignant.</p>\n<p>Grade 3: &gt;0% but &le;2% chance of being malignant</p>\n<p>Grade 4:</p>\n<ul>\n<li>4a: &gt;2 to &le;10% chance of being malignant</li>\n<li>4b: &gt;10 to &le;50% chance of being malignant</li>\n<li>4c: &gt;50 to &lt;95% chance of being malignant</li>\n</ul>\n<p>Grade 5: <span class=\"_Tgc _s8w\">&ge;</span>95% chance of being malignant</p><hr><h3>Related Pearl: BIRADS - Breast Imaging Reporting and Data System</h3><p>Breast Imaging Reporting and Data System <strong>(BI-RADS)</strong> standardizes the reporting for mammography and ultrasonography and helps guide decision making:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Category</strong></td>\n<td><strong>Definition</strong></td>\n<td><strong>% Chances of Malignancy</strong></td>\n<td><strong>Follow-up</strong></td>\n</tr>\n<tr>\n<td>0</td>\n<td>Incomplete assessment</td>\n<td>Not applicable</td>\n<td>Additional imaging evaluation</td>\n</tr>\n<tr>\n<td>1</td>\n<td>Negative</td>\n<td>Essentially 0%</td>\n<td>Annual screening</td>\n</tr>\n<tr>\n<td>2</td>\n<td>Benign finding</td>\n<td>Essentially 0%</td>\n<td>Annual screening</td>\n</tr>\n<tr>\n<td>3</td>\n<td>Probably benign finding</td>\n<td>&gt;0% but ≤2%</td>\n<td>6 monthly mammograms for the next 2 years</td>\n</tr>\n<tr>\n<td>4\n<p> </p>\n</td>\n<td colspan=\"2\">\n<p>4A: low level of suspicion for malignancy &gt;2% to ≤10%</p>\n<p>4B: moderate suspicion for malignancy &gt;10% to ≤50%</p>\n<p>4C: high suspicion for malignancy &gt;50% to &lt;95%</p>\n</td>\n<td>Biopsy</td>\n</tr>\n<tr>\n<td>5</td>\n<td>Highly suggestive of malignancy </td>\n<td>≥95%</td>\n<td>Appropriate action should be taken </td>\n</tr>\n<tr>\n<td>6</td>\n<td colspan=\"2\">Known biopsy-proven malignancy</td>\n<td>Appropriate treatment</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9859",
      "difficulty": "medium"
    },
    {
      "text": "A 36-year-old pregnant lady was referred to the surgery OPD at 12 weeks of gestation with a lump in her right breast for the past 1 month. On examination, a lump of 2 x 1 cm size was palpated in the upper outer quadrant of the breast. Which of the following investigations would you initially advise her for the assessment of the breast lump?",
      "choices": [
        {
          "id": 1,
          "text": "Conventional mammography"
        },
        {
          "id": 2,
          "text": "Ultrasonography"
        },
        {
          "id": 3,
          "text": "MRI"
        },
        {
          "id": 4,
          "text": "Tomosynthesis with 2D mammography"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Ultrasonography (USG</strong>) is the preferred <strong>initial</strong> investigation in <strong>pregnant women</strong> who present with a breast lump. It can differentiate between solid and cystic lesions of the breast and is able to detect abnormal axillary lymph nodes.&nbsp;USG is preferred in women with<strong> dense breast tissue</strong> such as:</p>\n<ul>\n<li aria-level=\"1\">Pregnant women</li>\n<li aria-level=\"1\">Lactating women</li>\n<li aria-level=\"1\">Young women (less than 40 years old)&nbsp;</li>\n</ul>\n<p><strong>Conventional Mammography/ Tomosynthesis with 2D mammography</strong> is <strong>less useful</strong> in pregnant women due to the <strong>increased density</strong> of breast tissue.</p>\n<p><strong>MRI</strong> is <strong>not the initial</strong> investigation used for the assessment of breast lumps. It can be used in cases where metastasis or spread to other breasts is suspected.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0365",
      "difficulty": "easy"
    },
    {
      "text": "A USG can detect lymph node metastases in a patient with breast cancer and clinically negative lymph nodes by what percentage?",
      "choices": [
        {
          "id": 1,
          "text": "50 – 60%"
        },
        {
          "id": 2,
          "text": "10 – 20%"
        },
        {
          "id": 3,
          "text": "20 – 30%"
        },
        {
          "id": 4,
          "text": "30 – 50%"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>A <strong>USG</strong> can detect lymph node metastasis in a patient with clinically negative lymph nodes by <strong>50-60%</strong>.</p>\n<p>The <strong>clinical determination</strong> of axillary lymph node metastases has an accuracy of only<strong> 33%</strong>.</p>\n<p>Ultrasound (<strong>USG</strong>) is <strong>more sensitive</strong> than physical examination alone in determining axillary lymph node involvement during the preliminary staging of breast carcinoma.&nbsp;</p>\n<p><strong>Fine-needle aspiration cytology (FNAC) or core biopsy</strong> of sonographically indeterminate or suspicious lymph nodes can provide a more definitive diagnosis than USG alone.</p>\n<p>Ultrasonography can also be utilized to image the regional lymph nodes in patients with breast cancer. The <strong>sensitivity</strong> for the status of axillary nodes ranges from <strong>35% to 82%</strong> and <strong>specificity</strong> ranges from <strong>73% to 97%</strong>.</p>\n<p><strong>The features of a lymph node involved with cancer on USG include</strong>:</p>\n<ul>\n<li aria-level=\"1\">Cortical thickening</li>\n<li aria-level=\"1\">Change in shape of the node to a more circular appearance</li>\n<li aria-level=\"1\">Size larger than 10 mm&nbsp;</li>\n<li aria-level=\"1\">Absence of a fatty hilum</li>\n<li aria-level=\"1\">Hypoechoic internal echoes</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC9327",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following features on USG will not be suggestive of breast malignancy?",
      "choices": [
        {
          "id": 1,
          "text": "Thin echogenic pseudo-capsule"
        },
        {
          "id": 2,
          "text": "Hypo-echoic lesion"
        },
        {
          "id": 3,
          "text": "Central vascularity"
        },
        {
          "id": 4,
          "text": "Lump will be taller than wider"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Malignant breast lump</strong> on USG, has an <strong>ill-defined echogenic halo</strong>, is hypoechoic, and the lump will be taller than wider. <strong>Benign breast lumps</strong> have a <strong>thin echogenic pseudo-capsule</strong> on USG.</p><hr><h3>Related Pearl: Differentiating features of benign and malignant breast lump on USG</h3><table>\n<tbody>\n<tr>\n<td><strong>Benign lump</strong></td>\n<td><strong>Malignant lump</strong></td>\n</tr>\n<tr>\n<td>Hyper echoic</td>\n<td>Hypo echoic</td>\n</tr>\n<tr>\n<td>Oval, well circumscribed lump</td>\n<td>Lump will be taller than wider</td>\n</tr>\n<tr>\n<td>Thin echogenic pseudocapsule</td>\n<td>Ill defined echogenic halo</td>\n</tr>\n<tr>\n<td>Peripheral vascularity</td>\n<td>Central vascularity</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li>Most sensitive and most common finding of malignancy on USG &ndash; Lump will be taller than wider.</li>\n<li><strong>Most specific finding</strong> of malignancy on USG &ndash; <strong>Central vascularity</strong></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0358",
      "difficulty": "medium"
    },
    {
      "text": "A young female patient presents to the clinic with a painless lump in her right breast. She underwent breast augmentation surgery 3 years back. Which of the following will be the best investigation to assess the breast tissue in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Tomosynthesis"
        },
        {
          "id": 2,
          "text": "Ultrasonography"
        },
        {
          "id": 3,
          "text": "Magnetic resonance imaging"
        },
        {
          "id": 4,
          "text": "Computed tomography"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Magnetic resonance imaging (<strong>MRI</strong>) is the <strong>best investigation</strong> to assess <strong>breast tissue</strong> in a patient with a <strong>breast implant</strong>.</p>\n<p><strong>MRI of the breast is also used in</strong>:</p>\n<ul>\n<li aria-level=\"1\">Screening of high-risk individuals with a positive family history.</li>\n<li aria-level=\"1\">Assessing loco-regional spread (multifocality and multicentricity) of carcinoma.</li>\n<li aria-level=\"1\">To differentiate scar from recurrence in women who have had breast conservation surgery for breast cancer.</li>\n</ul>\n<p>Option A: <strong>Tomosynthesis</strong> is not preferred, as radio-opaque implants are usually compressed together with the breast tissue, obscuring the visibility and thereby reducing its sensitivity.</p>\n<p>Option B: <strong>Ultrasonography</strong> is used as an initial investigation in the evaluation of breast abnormalities in patients with breast implants.</p>\n<p>Option D: <strong>Computed tomography</strong> is not routinely used in the evaluation of breast lumps.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0361",
      "difficulty": "easy"
    },
    {
      "text": "A 40-year-old woman with an elder sister with BRCA1 gene mutation presented to the OPD with a normal mammography report. Which of the following is the next preferred investigation to further evaluate this patient?",
      "choices": [
        {
          "id": 1,
          "text": "USG"
        },
        {
          "id": 2,
          "text": "MRI"
        },
        {
          "id": 3,
          "text": "Trucut biopsy"
        },
        {
          "id": 4,
          "text": "Repeat mammography after 6 months"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In the given scenario, since the patient is at <strong>high risk for breast malignancy</strong> (first degree relative with BRCA1 gene mutation), <strong>MRI followed by trucut biopsy</strong> will be the appropriate next step for further evaluation.</p>\n<p><strong>MRI</strong> is helpful in the screening of <strong>high-risk individuals</strong> and is the <strong>most sensitive</strong> imaging modality. However, it should be done after initial radiological evaluation, in case the results are inconclusive.</p>\n<p><strong>American Cancer Society Risk Criteria for Breast Magnetic Resonance Imaging Screening:</strong></p>\n<p><strong>Women at high lifetime risk</strong> (&asymp;20%-25% or greater) of breast cancer-</p>\n<ol>\n<li aria-level=\"1\">Known BRCA1 or BRCA2 gene mutation</li>\n<li aria-level=\"1\">First-degree relatives with BRCA1 or BRCA2 gene mutation, but have not had genetic testing themselves.</li>\n<li aria-level=\"1\">Radiation therapy to the chest between the ages of 10 and 30 years</li>\n<li aria-level=\"1\">Li-Fraumeni syndrome or Cowden syndrome or a first-degree relative with one of these syndromes.</li>\n</ol>\n<p>Women with a personal history of breast cancer, ductal carcinoma in situ, lobular carcinoma in situ, atypical ductal hyperplasia, or atypical lobular hyperplasia, are at a<strong> moderately increased lifetime risk</strong> for breast cancer.&nbsp;</p>\n<p>Options A &amp; D: <strong>Breast tomosynthesis or repeat mammography</strong> is not preferred as the next investigation in high-risk patients.&nbsp;</p>\n<p>Option C: <strong>Trucut biopsy</strong> will be done following MRI in high-risk patients.</p><hr><h3>Related Pearl: Breast Cancer Screening</h3><p><strong>Breast Cancer Screening</strong></p>\n<p>Individuals are encouraged to conduct a <strong>risk assessment by 25 years of age</strong>. This helps classify them into <strong>average risk</strong> or <strong>increased risk groups</strong>.</p>\n<p>Recommendations<strong>:</strong>&nbsp;</p>\n<ol>\n<li aria-level=\"1\"><strong>Average-risk</strong>&nbsp;(no known genetic or family history of breast cancer)</li>\n<ul>\n<li aria-level=\"1\">25-39 years of age: clinical breast examination every 1-3 years;&nbsp;</li>\n<li aria-level=\"2\">&ge; 40 years of age: clinical breast examination and mammogram annually</li>\n</ul>\n<li aria-level=\"1\"><strong>High-risk </strong>(positive family or genetic history of breast cancer)</li>\n<ul>\n<li aria-level=\"2\">Consult a healthcare professional&nbsp;every <strong>6-12 months</strong> <strong>after 21 years of age</strong></li>\n<li aria-level=\"2\"><strong>Annual mammogram or MRI</strong> from 25 years of age or 10 years prior to the age at which the youngest family member was diagnosed with breast cancer (whichever is earliest)</li>\n</ul>\n<li aria-level=\"1\"><strong>Asymptomatic women</strong> with <strong>previously treated breast cancer</strong></li>\n<ul>\n<li aria-level=\"2\">Consult a healthcare professional&nbsp;every <strong>6-12 months</strong></li>\n<li aria-level=\"2\"><strong>Annual mammogram</strong></li>\n<li aria-level=\"2\">Annual MRI to be considered</li>\n</ul>\n<li aria-level=\"1\">Mammogram and USG are&nbsp;<strong>not contraindicated</strong> in <strong>pregnant and breastfeeding</strong> women</li>\n</ol>\n<p><strong>High-risk patients</strong> for breast cancer:</p>\n<ol>\n<li aria-level=\"1\">Women (or a first-degree relative) with a known BRCA1 or BRCA2 mutation or TP53 or PTEN genes</li>\n<li aria-level=\"1\">Two first-degree relatives with breast cancers with or without gene mutations</li>\n<li aria-level=\"1\">Women with a history of chest irradiation between the ages of 10 and 30</li>\n<li aria-level=\"1\">Women with previously biopsy-proven breast cancer</li>\n<li aria-level=\"1\">Women with &ge; 20% lifetime risk for breast cancer based on breast cancer risk models</li>\n</ol>\n<p>*According to <strong>NCCN 2022 guidelines</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0366",
      "difficulty": "medium"
    },
    {
      "text": "A postmenopausal woman who was on HRT for the past 2 years, presented with a 4 x 3cm lump over the upper outer quadrant of the left breast. On examination, a peau d’orange appearance was seen and a hard and fixed lump was palpated over the breast.  Which of the following is the investigation of choice to confirm the diagnosis in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Excisional biopsy"
        },
        {
          "id": 2,
          "text": "Trucut biopsy"
        },
        {
          "id": 3,
          "text": "Fine-needle aspiration cytology"
        },
        {
          "id": 4,
          "text": "Tomosynthesis with 2D mammography"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The history and physical examination point towards a diagnosis of <strong>breast malignancy</strong>. The <strong>investigation of choice</strong> for <strong>confirmation</strong> of breast carcinoma is <strong>trucut biopsy/core-needle biopsy</strong>. An excisional biopsy can be done, in case it is inconclusive.</p>\n<p><strong>Trucut needle biopsy</strong> permits the analysis of <strong>breast tissue architecture</strong>. A <strong>14 G- 16 G</strong> needle is used. The advantages include a low complication rate, minimal scarring, and a lower cost as compared to excisional breast biopsy. </p>\n<p>Fine-needle aspiration cytology (<strong>FNAC</strong>) is a <strong>cytological</strong> investigation and, hence, not the investigation of choice. A <strong>22-30 G</strong> needle is used for FNAC.</p>\n<p><strong>Trucut biopsy is preferred over FNAC</strong> as it:</p>\n<ul>\n<li aria-level=\"1\">Allows a definitive preoperative diagnosis</li>\n<li aria-level=\"1\">Differentiates between DCIS and invasive disease</li>\n<li aria-level=\"1\">Allows the tumor to be stained for receptor status, which is important for starting neoadjuvant therapy. </li>\n</ul>\n<p>Image-guided biopsy is used only in the case of non-palpable lesions.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9852",
      "difficulty": "easy"
    },
    {
      "text": "As a surgery resident, which of the following will you perform in a patient with suspected breast malignancy as part of the triple assessment?<div class='question-desc-html'><p>1. History<br />2. Clinical examination<br />3. Radiological investigations<br />4. Histopathological examination</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "1,2, 3 and 4"
        },
        {
          "id": 2,
          "text": "2, 3 and 4"
        },
        {
          "id": 3,
          "text": "1, 2 and 3"
        },
        {
          "id": 4,
          "text": "1, 3 and 4"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Triple assessment</strong> in relation to breast carcinoma includes the following:</p>\n<ul>\n<li aria-level=\"1\">Clinical assessment includes both <strong>history and clinical examination</strong></li>\n<li aria-level=\"1\">Radiological imaging, including ultrasonography (USG) and/or mammography</li>\n<li aria-level=\"1\">Histopathological examination (HPE), including fine-needle aspiration cytology (FNAC) and/or Tru-Cut biopsy</li>\n</ul>\n<p>The positive predictive value of the triple assessment is 99.9%.</p>\n<p>Note:<strong>&nbsp;</strong>Bailey &amp; Love 27th Ed mentions that clinical assessment, radiological imaging, and HPE constitute triple assessment. However, <strong>clinical assessment includes both history and clinical examination. </strong>Hence, history is a part of the triple assessment.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0364",
      "difficulty": "medium"
    },
    {
      "text": "An actress with bilateral silicone breast implants presents for regular follow-up. On radiological evaluation, she was found to have signs suggestive of intracapsular breast implant rupture. Which of the following named signs will you see on imaging?<div class='question-desc-html'><ol>\n<li aria-level=\"1\">Stepladder sign (on USG)</li>\n<li aria-level=\"1\">Keyhole sign (Mammography)</li>\n<li aria-level=\"1\">Snowstorm sign (on Xray)</li>\n<li aria-level=\"1\">Linguine sign (MRI)</li>\n<li aria-level=\"1\">Comet tail sign (CT scan)</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 2, 3 & 4"
        },
        {
          "id": 2,
          "text": "2 & 5"
        },
        {
          "id": 3,
          "text": "1 & 4"
        },
        {
          "id": 4,
          "text": "1, 3 & 5"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Linguine sign (on MRI)</strong> and <strong>Stepladder sign (on USG)</strong> are specific for <strong>intracapsular breast implant rupture</strong>.</p>\n<p>After implantation of a silicone or saline&nbsp;breast implant, a fibrous capsule (scar) forms around the implant shell. In an intracapsular rupture, the contents of the implant are contained by the fibrous scar, while the free-floating shell appears as a group of&nbsp;<strong>wavy lines</strong>&nbsp;(like the Italian linguine pasta as shown below). Hence, this has been termed the \"linguine sign\".</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/efbfc0dc10ea4e4b9e81a33773c1f114x512x219.PNG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/533e0a52aa664aa4981be238df9cc447x1024x683.JPEG\" alt=\"Explanation Image\"><p><strong>Stepladder sign (seen on USG)</strong> is identified as multiple, discontinuous, parallel, linear echoes in the lumen as shown below.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/077bdfdcb20e41998f4995ff58542e54x512x171.PNG\" alt=\"Explanation Image\"><p><strong>Snowstorm sign (seen on USG</strong>) is seen in extracapsular rupture of breast implant.</p>\n<p><strong>Comet tail sign</strong> is a finding that can be seen on chest CT. The comet-tail sign is produced by the distortion of vessels and bronchi that lead to an adjacent area of round atelectasis, which is the mass. The bronchovascular bundles appear to be pulled into the mass and resemble a comet tail.</p>\n<p>Note: Detection of intracapsular silicone ruptures is almost impossible on mammography.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9874",
      "difficulty": "medium"
    },
    {
      "text": "A woman came with complaints of breast pain following surgery. Her MRI is shown below. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Extra-capsular silicone rupture"
        },
        {
          "id": 2,
          "text": "Contracture and calcification"
        },
        {
          "id": 3,
          "text": "Intra-capsular silicone rupture"
        },
        {
          "id": 4,
          "text": "Breast abscess"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The above image shows curvilinear hypointense lines (arrows) in the left breast implant indicative of the collapsed shell floating in the silicone gel. This is called the<strong> linguine sign</strong>&nbsp;that is seen in&nbsp;<strong>intra-capsular rupture&nbsp;of a breast implant. </strong></p>\n<p>After implantation of a silicone or saline&nbsp;breast implant, a fibrous capsule (scar) forms around the implant shell. In an intracapsular rupture, the contents of the implant are contained by the fibrous scar, while the shell appears as a group of wavy lines.</p>\n<p>This has been termed the \"linguine sign\" and has been most commonly described with MR imaging.</p>\n<p>Multiple hyperintense foci on T2-weighted images are sometimes found within the implant lumen. These findings are referred to as the <strong>salad oil sign</strong>&nbsp;or <strong>droplet sign</strong>.</p>\n<p>Indications for <strong>breast MRI</strong>:</p>\n<ul>\n<li>Screening for DCIS in <strong>high-risk</strong> patients</li>\n<li>Evaluation of breast <strong>implants</strong></li>\n<li>Evaluation of breast scar tissue versus recurrent tumors.</li>\n</ul>\n<p>Ultrasound is the preferred modality of imaging in suspected cases of extracapsular rupture. The <strong>s</strong><strong>nowstorm sign </strong>on USG&nbsp;is seen in&nbsp;<strong>extracapsular</strong>&nbsp;rupture.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/705643f457fa4facb315426db0d36d99.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5657",
      "difficulty": "easy"
    },
    {
      "text": "A 50-year-old female patient presents with a 4*3cm irregular mass in the upper outer quadrant of the right breast, which is not fixed to the skin or the chest wall. A lymph node of 2cm is palpated in the right axilla. No mass is palpated in the opposite breast. Which of the following investigations would you perform on this patient?<div class='question-desc-html'><ol>\n<li>Bilateral mammography</li>\n<li>PET Scan</li>\n<li>Biopsy of the breast mass</li>\n<li>USG guided biopsy of the lymph node</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 2, 3 & 4"
        },
        {
          "id": 2,
          "text": "1, 2 & 3"
        },
        {
          "id": 3,
          "text": "1, 3 & 4"
        },
        {
          "id": 4,
          "text": "1 & 3"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario is suggestive of <strong>breast malignancy </strong>with locoregional spread with unlikely distant metastasis.  For further evaluation of this lesion, <strong>bilateral mammography, a biopsy </strong>of the breast<strong> mass </strong>and a <strong>USG-guided biopsy </strong>of the <strong>suspicious lymph node</strong> need to be performed in order to determine staging and decide on further management. </p>\n<p>Statement 2:<strong> PET Scan</strong> is usually performed in advanced cases of breast cancer. It is not routinely used in the assessment of locoregional disease.</p>\n<p>Statement 1:<strong> Diagnostic mammography</strong> is used to evaluate women with abnormal findings such as a breast mass or nipple discharge. Mammography is more accurate than clinical examination for the detection of early breast cancers. <strong>Mammographic features suggestive of breast cancer</strong> include a solid mass with or without stellate features, microcalcifications, irregular soft tissue shadow, spiculations and duct distortion.</p>\n<p>Statement 3:<strong> Pathological diagnosis</strong> of carcinoma is made by a core needle biopsy (<strong>tru-cut biopsy</strong>) or fine-needle aspiration before any type of treatment is started. </p>\n<p>Statement 4: The presence or absence of axillary lymph node involvement in breast cancer is one of the most important prognostic factors for determining staging and treatment. <strong>Ultrasound-guided lymph node biopsy</strong> should be done in patients with suspicious or clinically palpable lymph nodes. </p>\n<p><strong>Ultrasound features</strong> suggestive of breast cancer include a hypoechoic, irregular mass with indistinct, angulated or spiculated margins, acoustic shadowing, ductal extension and a branched pattern of mass.</p><hr><h3>Related Pearl: Differentiating features of benign and malignant breast lump on USG</h3><table>\n<tbody>\n<tr>\n<td><strong>Benign lump</strong></td>\n<td><strong>Malignant lump</strong></td>\n</tr>\n<tr>\n<td>Hyper echoic</td>\n<td>Hypo echoic</td>\n</tr>\n<tr>\n<td>Oval, well circumscribed lump</td>\n<td>Lump will be taller than wider</td>\n</tr>\n<tr>\n<td>Thin echogenic pseudocapsule</td>\n<td>Ill defined echogenic halo</td>\n</tr>\n<tr>\n<td>Peripheral vascularity</td>\n<td>Central vascularity</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li>Most sensitive and most common finding of malignancy on USG &ndash; Lump will be taller than wider.</li>\n<li><strong>Most specific finding</strong> of malignancy on USG &ndash; <strong>Central vascularity</strong></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6806",
      "difficulty": "medium"
    },
    {
      "text": "A 22-year-old woman is found to have the BRCA1 mutation. She got herself tested after her mother’s death due to breast cancer with a BRCA1 mutation. At what age and with which modality would you start breast cancer screening in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "40 years - Mammogram"
        },
        {
          "id": 2,
          "text": "40 years - MRI"
        },
        {
          "id": 3,
          "text": "25 years - USG"
        },
        {
          "id": 4,
          "text": "25 years - MRI + Mammogram"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Patients with <strong>BRCA mutations</strong> or <strong>positive</strong> known <strong>first-degree</strong> family history are considered <strong>high-risk patients</strong>. These patients need to undergo <strong>annual screening MRI + Mammogram</strong> from the age of <strong>25yrs.</strong></p>\n<p>Patients with a family history of breast cancer but no known gene mutation should also start screening before 40 years. Screening should begin <strong>10 years before</strong> the earliest age of diagnosis of breast cancer in the first-degree relative. E.g- If the mother was detected with breast cancer at 40 years of age, the daughter should start screening by the age of 30 years.</p>\n<p><strong>High-risk patients</strong> for breast cancer:</p>\n<ol>\n<li aria-level=\"1\">Women with a known BRCA1 or BRCA2 mutation</li>\n<li aria-level=\"1\">Two first-degree relatives with breast cancers with or without gene mutations</li>\n<li aria-level=\"1\">Women with a history of chest irradiation between the ages of 10 and 30</li>\n<li aria-level=\"1\">2 or more cases of breast cancer &lt; 50 years old in the family</li>\n<li aria-level=\"1\">Mutation (or a first-degree relative with a mutation) in the TP53 or PTEN genes</li>\n</ol><hr><h3>Related Pearl: Breast Cancer Screening</h3><p><strong>Breast Cancer Screening</strong></p>\n<p>Individuals are encouraged to conduct a <strong>risk assessment by 25 years of age</strong>. This helps classify them into <strong>average risk</strong> or <strong>increased risk groups</strong>.</p>\n<p>Recommendations<strong>:</strong>&nbsp;</p>\n<ol>\n<li aria-level=\"1\"><strong>Average-risk</strong>&nbsp;(no known genetic or family history of breast cancer)</li>\n<ul>\n<li aria-level=\"1\">25-39 years of age: clinical breast examination every 1-3 years;&nbsp;</li>\n<li aria-level=\"2\">&ge; 40 years of age: clinical breast examination and mammogram annually</li>\n</ul>\n<li aria-level=\"1\"><strong>High-risk </strong>(positive family or genetic history of breast cancer)</li>\n<ul>\n<li aria-level=\"2\">Consult a healthcare professional&nbsp;every <strong>6-12 months</strong> <strong>after 21 years of age</strong></li>\n<li aria-level=\"2\"><strong>Annual mammogram or MRI</strong> from 25 years of age or 10 years prior to the age at which the youngest family member was diagnosed with breast cancer (whichever is earliest)</li>\n</ul>\n<li aria-level=\"1\"><strong>Asymptomatic women</strong> with <strong>previously treated breast cancer</strong></li>\n<ul>\n<li aria-level=\"2\">Consult a healthcare professional&nbsp;every <strong>6-12 months</strong></li>\n<li aria-level=\"2\"><strong>Annual mammogram</strong></li>\n<li aria-level=\"2\">Annual MRI to be considered</li>\n</ul>\n<li aria-level=\"1\">Mammogram and USG are&nbsp;<strong>not contraindicated</strong> in <strong>pregnant and breastfeeding</strong> women</li>\n</ol>\n<p><strong>High-risk patients</strong> for breast cancer:</p>\n<ol>\n<li aria-level=\"1\">Women (or a first-degree relative) with a known BRCA1 or BRCA2 mutation or TP53 or PTEN genes</li>\n<li aria-level=\"1\">Two first-degree relatives with breast cancers with or without gene mutations</li>\n<li aria-level=\"1\">Women with a history of chest irradiation between the ages of 10 and 30</li>\n<li aria-level=\"1\">Women with previously biopsy-proven breast cancer</li>\n<li aria-level=\"1\">Women with &ge; 20% lifetime risk for breast cancer based on breast cancer risk models</li>\n</ol>\n<p>*According to <strong>NCCN 2022 guidelines</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF4008",
      "difficulty": "medium"
    },
    {
      "text": "A young woman with a distant breast cancer relative comes to you in the clinic. You are advising her to practice self-examination of her breasts. Which of the following statements is incorrect regarding this practice?",
      "choices": [
        {
          "id": 1,
          "text": "It should be done once a month, every month"
        },
        {
          "id": 2,
          "text": "Ideally, be done between the 3rd to 6th day of the menstrual cycle"
        },
        {
          "id": 3,
          "text": "It should only be done while standing"
        },
        {
          "id": 4,
          "text": "The examination should be done by using the middle three fingerpads"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Self-examination of breasts</strong> can be done while <strong>standing</strong> or <strong>lying down.</strong></p>\n<p>It should be ideally be done <strong>once</strong> <strong>a month, every month</strong> between the <strong>3rd to 6th day</strong> of the <strong>menstrual cycle.</strong> If the periods are irregular or the patient is post-menopausal, then the patient can pick any day of the month. </p>\n<p>It can be done any time of the day while showering, dressing, standing, or lying down at night.</p>\n<p>Steps of the<strong> self-examination:</strong></p>\n<ol>\n<li aria-level=\"1\">Visual inspection: See for any abnormalities, like shape, size, dimpling, puckering of the skin, nipple discharge, etc.</li>\n<li aria-level=\"1\">Manual inspection: It is done by using the middle three fingerpads. Feel for any lumps. Techniques used are (either one of them): \n<ul>\n<li aria-level=\"1\"><strong>Horizontal stripes method</strong></li>\n<li aria-level=\"1\"><strong>Vertical stripes method</strong></li>\n<li aria-level=\"1\"><strong>Dial clock method</strong></li>\n</ul>\n</li>\n</ol>\n<p>Be sure to check under the areola and press the nipple gently to check for any <strong>discharge.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/504a22df2e1245329a35d71199e408c6x344x208.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF4007",
      "difficulty": "medium"
    }
  ]
}